ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,651Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 2588

$1.27M Total Retail Price of All Prescriptions

Rank: 47 out of 2588

609 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 609 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

17% of this provider’s 609 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 18,074 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
SIMVASTATIN 987 779 1 1
WARFARIN SODIUM 979 855 2 10
FUROSEMIDE 834 683 3 5
LEVOTHYROXINE SODIUM 807 604 4 2
AMLODIPINE BESYLATE 762 620 5 4
OMEPRAZOLE 762 539 5 6
LISINOPRIL 647 536 7 3
METOPROLOL TARTRATE 550 432 8 9
POLYETHYLENE GLYCOL 3350 486 145 9 55
HYDROCODONE-ACETAMINOPHEN 448 271 S3 10 7
FAMOTIDINE 424 271 11 36
SERTRALINE HCL 377 350 12 26
RANITIDINE HCL 362 222 13 37
METFORMIN HCL 329 210 14 8
CITALOPRAM HBR 326 253 15 27
DONEPEZIL HCL 312 291 16 22
GABAPENTIN 293 164 17 18
METOPROLOL SUCCINATE 278 245 18 12
PANTOPRAZOLE SODIUM 274 219 19 28
RISPERIDONE 274 169 19 57
POTASSIUM CHLORIDE 266 245 21 15
KLOR-CON M20 258 186 22 52
NAMENDA 256 245 23 32
GLIPIZIDE 254 204 24 44
CARBAMAZEPINE 245 0 25 146
ALENDRONATE SODIUM 235 180 26 21
MIRTAZAPINE 235 226 26 63
LEVETIRACETAM 235 90 26 90
ATORVASTATIN CALCIUM 211 166 29 11
LEVOFLOXACIN 189 126 30 77
TRAZODONE HCL 186 107 31 61
CLOPIDOGREL 182 145 32 30
TRAMADOL HCL 178 151 33 19
ENALAPRIL MALEATE 170 119 34 31
DIOVAN 169 163 35 29
LANTUS 166 124 36 47
CARVEDILOL 160 137 37 20
ZOLPIDEM TARTRATE 159 123 38 24
QUETIAPINE FUMARATE 158 98 39 74
BACLOFEN 154 46 40 142
DIVALPROEX SODIUM 153 39 41 89
TAMSULOSIN HCL 152 126 42 23
HEPARIN SODIUM 151 149 43 79
HYDROCHLOROTHIAZIDE 150 108 44 13
ALBUTEROL SULFATE 142 66 45 116
CRESTOR 135 110 46 25
NYSTATIN-TRIAMCINOLONE 125 68 47 158
LIDODERM 121 115 48 86
TRICOR 121 68 48 122
LYRICA 118 54 50 100
HYDRALAZINE HCL 115 104 51 53
CEPHALEXIN 113 61 52 138
SODIUM CHLORIDE 112 37 53 168
ALLOPURINOL 109 98 54 33
SYMBICORT 107 69 55 129
CARBIDOPA-LEVODOPA 106 99 56 83
PRAVASTATIN SODIUM 105 103 57 16
KLOR-CON M10 105 102 57 139
JANUVIA 103 88 59 60
BUMETANIDE 102 91 60 117
FENOFIBRATE 102 70 60 64
PLAVIX 101 90 62 43
PAROXETINE HCL 98 68 63 71
AZITHROMYCIN 97 64 64 45
FLUTICASONE PROPIONATE 96 47 65 40
LAMOTRIGINE 95 23 66 170
NYSTATIN 94 42 67 196
LOVASTATIN 93 78 68 34
LANTUS SOLOSTAR 92 77 69 93
FINASTERIDE 88 88 70 97
NOVOLOG 88 74 70 103
CIPROFLOXACIN HCL 86 56 72 82
PREDNISONE 83 72 73 42
ADVAIR DISKUS 82 70 74 48
LOSARTAN POTASSIUM 81 66 75 17
LACTULOSE 81 11 75 135
CYCLOBENZAPRINE HCL 78 39 R 77 87
CELEBREX 78 65 77 99
TOPIRAMATE 77 19 79 167
ISOSORBIDE MONONITRATE ER 75 75 80 49
PEN NEEDLE 74 46 81 112
EXELON 73 69 82 118
OLANZAPINE 72 62 83 126
ATENOLOL 72 54 83 14
CLOTRIMAZOLE-BETAMETHASONE 71 58 85 155
DIGOXIN 71 69 85 38
SPIRIVA 69 56 87 56
TRIAMTERENE-HCTZ 68 55 88 46
ABILIFY 68 45 88 134
IPRATROPIUM BROMIDE 67 25 90 159
METOCLOPRAMIDE HCL 66 47 91 136
VANCOMYCIN HCL 66 37 91 265
VESICARE 65 51 93 172
MELOXICAM 64 54 94 51
CYMBALTA 64 30 94 70
SPIRONOLACTONE 63 50 96 58
TRIAMCINOLONE ACETONIDE 63 36 96 106
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 38 98 127
NOVOLOG FLEXPEN 62 58 98 205
LIPITOR 60 43 100 114
PHENYTOIN SODIUM EXTENDED 60 25 100 109
OXYBUTYNIN CHLORIDE 59 25 102 132
RAMIPRIL 59 40 102 111
GLYCOPYRROLATE 59 0 102 338
OXYBUTYNIN CHLORIDE ER 59 40 102 85
VALPROIC ACID 57 0 106 174
AMITRIPTYLINE HCL 57 20 R 106 91
CALCITONIN-SALMON 55 34 108 203
GLIMEPIRIDE 54 48 109 39
IPRATROPIUM-ALBUTEROL 52 39 110 104
AMOX TR-POTASSIUM CLAVULANATE 52 29 110 131
HUMALOG 50 17 112 141
SINGULAIR 50 36 112 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.